Rankings
▼
Calendar
TMCI (Treace Medical Concepts, Inc.) Stock Financials & Earnings | Market Cap Arena
TMCI
Treace Medical Concepts, Inc.
Mkt Cap
$104M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$213M
Net Income (TTM)
-$59M
EPS (TTM)
-$0.94
Free Cash Flow (TTM)
-$29M
Gross Margin
79.8%
Op. Margin
-25.5%
Net Margin
-27.7%
FCF Margin
-13.9%
P/S Ratio (TTM)
0.5x
P/E Ratio (TTM)
—
YoY Rev Growth
+1.6%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$42M
$34M
-$14M
Q2 23
$42M
$34M
-$13M
Q3 23
$41M
$33M
-$18M
Q4 23
$62M
$51M
-$7M
Q1 24
$51M
$41M
-$19M
Q2 24
$44M
$36M
-$21M
Q3 24
$45M
$36M
-$15M
Q4 24
$69M
$55M
-$204K
Q1 25
$53M
$42M
-$16M
Q2 25
$47M
$38M
-$17M
Q3 25
$50M
$40M
-$16M
Q4 25
$63M
$50M
-$6M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
0.7x
—
Q2 23
0.6x
—
Q3 23
0.6x
—
Q4 23
0.6x
—
Q1 24
0.5x
—
Q2 24
0.5x
—
Q3 24
0.5x
—
Q4 24
0.5x
—
Q1 25
0.5x
—
Q2 25
0.5x
—
Q3 25
0.5x
—
Q4 25
0.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$17M
-$19M
Q2 23
-$8M
-$13M
Q3 23
-$10M
-$13M
Q4 23
$532K
-$2M
Q1 24
-$7M
-$11M
Q2 24
-$14M
-$16M
Q3 24
-$12M
-$15M
Q4 24
-$4M
-$7M
Q1 25
$4M
$655K
Q2 25
-$3M
-$8M
Q3 25
-$9M
-$12M
Q4 25
-$8M
-$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$1M
Q2 23
$4M
Q3 23
$4M
Q4 23
$2M
Q1 24
$4M
Q2 24
$2M
Q3 24
$3M
Q4 24
$3M
Q1 25
$4M
Q2 25
$5M
Q3 25
$3M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+45.3%
+50.7%
Q2 23
+40.0%
+31.3%
Q3 23
+23.3%
+32.0%
Q4 23
+25.0%
+29.5%
Q1 24
+21.1%
+25.2%
Q2 24
+6.0%
+19.7%
Q3 24
+10.6%
+2.8%
Q4 24
+10.4%
-0.1%
Q1 25
+2.9%
-2.7%
Q2 25
+6.6%
-2.2%
Q3 25
+11.4%
+9.4%
Q4 25
-9.0%
-0.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
6.4%
Q2 23
$4M
8.6%
Q3 23
$5M
12.7%
Q4 23
$6M
9.4%
Q1 24
$7M
14.5%
Q2 24
$7M
15.2%
Q3 24
$8M
17.5%
Q4 24
$9M
12.5%
Q1 25
$9M
16.5%
Q2 25
$10M
20.2%
Q3 25
$8M
15.9%
Q4 25
$8M
12.1%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$3M
$11M
$34M
Q2 23
$4M
$10M
$34M
Q3 23
$4M
$13M
$34M
Q4 23
$4M
$13M
$40M
Q1 24
$5M
$14M
$40M
Q2 24
$5M
$14M
$38M
Q3 24
$5M
$14M
$33M
Q4 24
$5M
$14M
$37M
Q1 25
$6M
$16M
$36M
Q2 25
$5M
$16M
$33M
Q3 25
$5M
$16M
$33M
Q4 25
$5M
$15M
$38M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$30M
$141M
$171M
Q2 23
$12M
$127M
$139M
Q3 23
$7M
$115M
$122M
Q4 23
$13M
$110M
$123M
Q1 24
$9M
$101M
$110M
Q2 24
$18M
$77M
$95M
Q3 24
$12M
$71M
$83M
Q4 24
$11M
$64M
$76M
Q1 25
$13M
$63M
$76M
Q2 25
$8M
$61M
$69M
Q3 25
$8M
$50M
$57M
Q4 25
$11M
$38M
$48M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
59M
+5.7%
Q2 23
61M
+4.5%
Q3 23
62M
+0.3%
Q4 23
62M
+0.2%
Q1 24
62M
+0.2%
Q2 24
62M
+0.5%
Q3 24
62M
+0.2%
Q4 24
62M
+0.2%
Q1 25
63M
+0.5%
Q2 25
63M
+0.6%
Q3 25
64M
+0.8%
Q4 25
64M
+0.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$381K
248
FY 22
$335K
423
FY 23
$363K
516
FY 24
$439K
477
FY 25
$473K
450
marketcaparena.com